Wegovy

2023 - 11 - 13

Post cover
Image courtesy of "Reuters"

Novo Nordisk shares rise as Wegovy shows heart benefits beyond ... (Reuters)

Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of ...

Post cover
Image courtesy of "CBS News"

Wegovy weight-loss drug reduced risk of serious heart problems by ... (CBS News)

A new study from drugmaker Novo Nordisk found that its weight-loss drug Wegovy can reduce the risk of heart problems in people without diabetes, ...

Post cover
Image courtesy of "Investopedia"

Novo Nordisk ADRs Climb After Study Suggests Its Wegovy Showed ... (Investopedia)

Novo Nordisk reported a study indicated its diabetes and weight-loss drug, Wegovy, helped reduce risks of heart attack, stroke, or death from cardiovascular ...

Post cover
Image courtesy of "U.S. News & World Report"

Wegovy Cuts Heart Risks by 20% in Large Trial (U.S. News & World Report)

By Robin Foster HealthDay Reporter. (HealthDay). MONDAY, Nov. 13, 2023 (Healthday News) -- In a finding that could change the landscape of heart disease ...

Post cover
Image courtesy of "Forbes"

SELECT Trial Data On Weight Loss Drug Wegovy May Not Be ... (Forbes)

Data indicates cardiovascular protective benefits from taking the obesity drug Wegovy. It's unclear if this data will convince payers to change their ...

Diabetes stocks are surprise winners from Novo Nordisk's Wegovy ... (Morningstar.com)

By Eleanor Laise. Eli Lilly also scores, analysts say, as trial results leave door open for new obesity drug to top Wegovy's benefits.

Post cover
Image courtesy of "FiercePharma"

Novo Nordisk touts Wegovy's value for heart disease patients (FiercePharma)

Novo Nordisk presented showed that its obesity treatment Wegovy can help patients with heart disease, with benefits not due solely to weight loss.

Wegovy study details revive debate over GLP-1 impact on devices (MedTech Dive)

The data confirmed a cardiovascular benefit for heart patients and showed the drug could help pre-diabetic patients control their blood sugar.

Post cover
Image courtesy of "CBS News"

Wegovy weight loss drug has heart health benefits, study found (CBS News)

A clinical trial found it could reduce the risk of heart attack, stroke, or heart-related death in people with cardiovascular disease.

Taking Obesity Drug Wegovy May Reduce Heart Attack, Stroke Risk (WebMD)

People with heart disease who took the weight loss medicine Wegovy were significantly less likely to have a heart attack or stroke, results of a much ...

Wegovy study details revive debate over GLP-1 impact on devices (BioPharma Dive)

The data confirmed a cardiovascular benefit and showed the drug could help pre-diabetic people control their blood sugar. Published Nov. 13, 2023.

Post cover
Image courtesy of "Healthline"

Wegovy Can Help Reduce Heart Attack Risk by 28%, Study Finds (Healthline)

New evidence suggests that semaglutide, sold as Ozemipc or Wegovy, could have far-reaching beneficial effects for cardiovascular health and heart failure.

Explore the last week